Takeda
JapancompanyMale5.5Global Dominance: 0.01%Takeda Pharmaceutical Company Limited is a Japanese multinational biopharmaceutical company, headquartered in Osaka, Japan. Established in 1781, Takeda is one of the largest pharmaceutical companies in Asia, specializing in areas such as oncology, gastroenterology, and neuroscience. The company is committed to research-led innovation and has a strong global presence, with operations in over 70 countries. Takeda aims to enhance the quality of life for patients by developing effective therapies and advancing healthcare solutions.
Country presence
Recent news mentions
Takeda was defeated in the election by Abe.
長野県知事選、5選めざす阿部氏が当選確実 共産推薦の武田氏を破る [長野県]：朝日新聞Japan· 2026-08-09
Takeda is a newcomer running in the Nagano Prefecture gubernatorial election.
長野県知事選が告示 5選めざす阿部氏と新顔の武田氏の2人が立候補 [長野県]：朝日新聞Japan· 2026-07-23Takeda developed the dengue vaccine TAK-003, commercialized as Qdenga®.
Dengue en Panamá: la paradoja de una vacuna probada aquí, pero ausente en nuestro país
Panama· 2025-09-04
Takeda is a Japanese company that is part of the group announcing major investments in the United States.
Sanofi promet d’investir 20 milliards de dollars aux Etats-Unis
France· 2025-05-14
